Data as of Dec 26
| +0.07 / +0.47%|
The 2 analysts offering 12-month price forecasts for Osiris Therapeutics Inc have a median target of 16.50, with a high estimate of 26.00 and a low estimate of 7.00. The median estimate represents a +10.44% increase from the last price of 14.94.
The current consensus among 2 polled investment analysts is to Buy stock in Osiris Therapeutics Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.